Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.
Spahn
Martin
M
University Hospital Würzburg, Department of Urology and Pediatric Urology, Germany. Spahn_M@klinik.uni-wuerzburg.de
Joniau
Steven
S
Gontero
Paolo
P
Fieuws
Steffen
S
Marchioro
Giansilvio
G
Tombal
Bertrand
B
Kneitz
Burkhard
B
Hsu
Chao-Yu
CY
Van Der Eeckt
Katie
K
Bader
Pia
P
Frohneberg
Detlef
D
Tizzani
Alessandro
A
Van Poppel
Hein
H
D000368:Aged; D002277:Carcinoma / Q000097:blood / Q000401:mortality* / Q000601:surgery; D015331:Cohort Studies; D005060:Europe; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D011467:Prostate / Q000473:pathology / Q000601:surgery; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality* / Q000601:surgery; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
D017430:Prostate-Specific Antigen